News

Epitomee Medical Receives FDA Clearance for Innovative Capsule

Epitomee Medical Receives FDA Clearance for Innovative Capsule

Epitomee Medical and Its Recent FDA Clearance

Epitomee Medical Ltd. is making a significant impact in weight management with recent FDA clearance for the Epitomee® Capsule. This groundbreaking device offers a safe and effective prescription option for adults whose Body Mass Index (BMI) is between 25 and 40. Unlike traditional treatments, this capsule provides a drug-free alternative, designed to assist with weight management when used together with diet and exercise.

An Overview of the Epitomee® Capsule

The Epitomee® Capsule marks a major leap in weight management solutions, becoming a favored choice for individuals looking for sustainable weight loss methods. Housed in a self-administered ingestible capsule, this device operates mechanically rather than chemically. Once swallowed, it absorbs water and expands in the stomach, forming a three-dimensional matrix that fosters a sense of fullness, ultimately aiding in weight loss.

How It Works

This device functions entirely through a mechanical action within the gastrointestinal tract. As the Epitomee® Capsule fills with water, it takes up space in the stomach, simulating the feeling of having eaten. This unique method allows users to better control their appetite, offering a new tool in the struggle against obesity.

Clinical Evidence of Effectiveness

The FDA's clearance was based on thorough clinical evaluation, including the RESET study, which involved 279 participants at various sites across the U.S. This crucial trial showcased the capsule's capability to facilitate weight loss. The results were promising: participants using the capsule experienced notably greater weight loss compared to those on the placebo. Impressively, 55.5% of those receiving the treatment achieved at least a 5% reduction in weight within 24 weeks.

Safety and Efficacy of the Capsule

The safety profile of the Epitomee® Capsule was a key focus during the RESET study. The treatment was generally well-tolerated, with fewer participants dropping out than in the control group. Notably, no serious adverse effects were reported while using the device. Participants also indicated improved quality of life, as measured by various health assessments.

Follow-Up Observations from the ELECT Study

To further evaluate its safety and effectiveness, researchers conducted a follow-up study known as the ELECT study, which monitored participants for an additional 24 weeks. This study confirmed that the Epitomee treatment remained effective and safe over the long term, demonstrating its potential as a lasting solution for weight management.

Expert Insights on FDA Clearance

Shimon Eckhouse, PhD, co-founder and chairman, shared his enthusiasm about the Epitomee® Capsule's FDA clearance. He remarked, "This is a significant milestone for weight management. This innovative approach provides a safe and effective option for patients, allowing them to manage their weight simply by taking a capsule."

Dan Hashimshony, PhD, CEO of Epitomee Medical, echoed this excitement, stating, "We are ecstatic about receiving FDA clearance for our groundbreaking solution. Our commitment is to address the obesity crisis with a product that ensures safety and efficacy for those dealing with weight management challenges." Their aim is to quickly launch this pioneering product in the U.S. market while forming strategic partnerships to unlock its full potential.

About Epitomee Medical Ltd.

Epitomee Medical, which trades publicly under the ticker symbol TASE: EPIT, was co-founded in 2005 with a mission to advance health solutions that prioritize safety and effectiveness. The company is dedicated not just to innovating weight management solutions but also to developing cutting-edge methods for biologic drug delivery. Epitomee Medical strives to remain at the forefront of transformative healthcare, continuously seeking ways to enhance the quality of life for patients worldwide.

Frequently Asked Questions

What is the Epitomee® Capsule designed for?

The Epitomee® Capsule aims to help adults with a BMI of 25-40 manage their weight effectively in conjunction with diet and exercise.

How does the capsule work?

The capsule absorbs water in the stomach, expanding to create a sensation of fullness that assists in appetite reduction.

What clinical trials support its safety and efficacy?

The device's safety and effectiveness were validated in the RESET and ELECT studies, involving more than 270 participants.

Who can benefit from the Epitomee® Capsule?

Adults facing challenges with weight management, particularly those with a BMI within the specified range, can gain from this innovative solution.

What is Epitomee Medical's vision?

Epitomee Medical is dedicated to delivering innovative and effective health solutions, emphasizing weight management and biologic drug delivery to improve patient outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 282

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 110

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

N3on and Iggy Azalea Elevate Online Gaming with MOTHERLAND

Updated Category News Views 459

N3on Partners with Iggy Azalea to Transform Online Gaming The partnership between N3on and Iggy Azalea marks an exciting evolution in the online gaming landscape, fusing pop culture with innovative technologies in the online casino space. This collaboration represents an incredible opportunity to reshape gaming entertainment by integrating a diverse array of experiences,...

Continue Reading
Quorum Information Technologies Set for Acquisition by Valsoft Corporation

Updated Category News Views 235

Quorum Information Technologies Reports Acquisition by Valsoft Quorum Information Technologies Inc. (TSX-V: QIS) has confirmed a definitive agreement for its acquisition by Valsoft Corporation, marking a strategic move for both companies. The all-cash transaction amounts to $0.80 for each outstanding common share of Quorum, a commendable offer that has been approved...

Continue Reading
New Funding Agreement to Support Bay Area Transit Systems

Updated Category News Views 250

Agreement Reached on Loan for Bay Area Transit Agencies In a significant development for the region, the Office of the Governor, the California Department of Finance, and the Metropolitan Transportation Commission (MTC) have announced a $590 million loan intended to support Bay Area transit agencies. This funding aims to prevent potential service cuts at critical transit...

Continue Reading
Uniti Group's Upcoming Presentation at the BofA Conference

Updated Category News Views 148

Uniti Group Inc. to Present at BofA Securities Conference Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) has recently announced an exciting opportunity for its leadership team to engage with investors during an upcoming financial conference. The company’s Senior Vice President, Chief Financial Officer, and Treasurer, Paul Bullington, along with Vice President of Investor...

Continue Reading
Fidelis Insurance Group Plans Fourth Quarter 2024 Results Release

Updated Category News Views 181

Fidelis Insurance Group's Upcoming Financial Results Announcement Fidelis Insurance Holdings Limited (NYSE:FIHL) is gearing up to share its financial performance for the fourth quarter that concluded in December 2024. This eagerly awaited release is scheduled for February 25, 2025, and will occur right after the financial markets conclude their daily functions. Investor...

Continue Reading